← Back to Search

Triphasic CT for Hepatitis C

N/A
Waitlist Available
Led By Christine Pocha, MD, PhD
Research Sponsored by Minneapolis Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will compare ultrasound and CT scanning for detecting early liver cancer in patients with advanced liver disease.

Eligible Conditions
  • Hepatitis C
  • Liver Disease
  • Liver Cirrhosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of screening measure to detect very early/early stage HCC (Barcelona Clinic Liver Cancer Staging System)
Secondary outcome measures
Cost - Effectiveness of screening measure

Trial Design

2Treatment groups
Active Control
Group I: Triphasic CTActive Control1 Intervention
Triphasic CT of the abdomen with and without contrast every 12 months with alpha-fetoprotein every 6 months.
Group II: UltrasoundActive Control1 Intervention
Ultrasound of the upper left quadrant with alpha-fetoprotein testing every 6 months.

Find a Location

Who is running the clinical trial?

Minneapolis Veterans Affairs Medical CenterLead Sponsor
72 Previous Clinical Trials
14,620 Total Patients Enrolled
1 Trials studying Hepatitis C
64 Patients Enrolled for Hepatitis C
Christine Pocha, MD, PhDPrincipal InvestigatorMinneapolis Veterans Affairs Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~13 spots leftby May 2025